Loblaw: We See Per Bank as a Strong CEO Hire, Given His Vast Industry Experience
No-moat Loblaw’s L search for its future CEO has concluded with the hiring of Per Bank, who will take the helm by early 2024. We think Bank is a great fit and don’t expect any dramatic changes to capital allocation, with ongoing investment in growth areas, including connected health, e-commerce, loyalty, and private label. Our sanguine stance is supported by Bank’s experience in his current role as CEO at Salling Group, which he has held since 2012. Like Loblaw, Denmark-based Salling is both the leading grocery chain in its home country and family-owned. Further, Salling has been investing beyond traditional grocery, as it has expanded into e-commerce, loyalty, and sustainability.
We have confidence that Loblaw will continue similar investment plans with the hiring of Bank, something we see as prudent. We like its expenditures in digital capabilities, as we believe this helps drive traffic. We also have a favorable view on Loblaw’s moves toward expanding its pharmaceutical practice. From our vantage point, recently acquired Lifemark Health Group and walk-in clinics utilizing excess space within its superstores dovetail well with Loblaw’s existing services in drug retail and should drive further foot traffic. We are maintaining our CAD 106 fair value estimate, leaving shares slightly overvalued. We plan to maintain our Standard capital allocation rating.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.